VDR Gene and Vitamin D: What the Variants Do and Don't Tell You

VDR Gene and Vitamin D: What the Variants Do and Don't Tell You

TL;DR: The VDR gene encodes the receptor through which active vitamin D regulates its target genes. Common variants such as FokI (rs2228570) and TaqI (rs731236) have been associated in studies with differences in how much people respond to vitamin D supplements. These are group-level findings. Your vitamin D status is measured and managed with the serum 25(OH)D blood test, not a genotype, and no clinical guideline uses VDR genotype to set a vitamin D dose.

Disclaimer: This article is for educational purposes. It does not constitute medical advice. Consult a healthcare professional for personalized guidance.

Low vitamin D is common. A pooled analysis of 7.9 million participants across 81 countries estimated that 47.9% had serum 25-hydroxyvitamin D levels below 50 nmol/L (Cui et al., Frontiers in Nutrition, 2023). That figure describes how common low levels are. It does not say why, and it is not evidence that genes explain it.

People taking the same supplement dose can end up with different blood levels. Researchers have asked whether genes contribute to that, and the VDR gene is one of the most studied candidates in nutrigenomics. The findings so far are associations in groups of people. They do not tell any one person how much vitamin D to take.

What Is the VDR Gene? Your Body's Vitamin D Interpreter

The VDR gene sits on chromosome 12q13.11 and encodes the vitamin D receptor — a nuclear transcription factor that serves as the primary mediator of vitamin D's biological effects. When the active form of vitamin D (1,25-dihydroxyvitamin D, also called calcitriol) binds this receptor, the VDR forms a heterodimer with the retinoid X receptor (RXR) and attaches to vitamin D response elements (VDREs) in the promoter regions of target genes. Its downstream targets are mainly involved in mineral metabolism, but it also regulates other pathways, such as those involved in the immune response (NCBI Gene).

Vitamin D receptor (VDR): a nuclear transcription factor encoded by the VDR gene on chromosome 12. When activated by calcitriol, it regulates target genes involved mainly in mineral metabolism, and also in immune function.

Vitamin D in your blood is the signal; the VDR protein is what receives it inside cells. Lab studies show that receptor variants can differ in activity. But there is no validated way to turn a VDR genotype into a measure of your own vitamin D status. That status is measured with the serum 25(OH)D blood test, and that test is what clinicians use to decide whether and how much to supplement.

The VDR protein is expressed in nearly every tissue in the body — not just bone and intestine (the classic vitamin D targets) but also immune cells, brain, muscle, pancreas, and skin. This wide distribution explains why vitamin D deficiency has been associated with conditions far beyond rickets, from autoimmune diseases to cardiovascular risk.

The Four Key VDR Variants: How Your Vitamin D Receptor Differs

Four single nucleotide polymorphisms in the VDR gene have been studied extensively across many populations and disease contexts.

FokI (rs2228570) — The One That Changes the Protein

FokI is the most functionally distinct VDR polymorphism. It is the only one that alters the actual structure of the VDR protein.

The polymorphism is a T-to-C change in the translation start codon. It decides where the ribosome starts reading, which gives two versions of the protein. On the gene's coding strand, the C allele (commonly called "F") removes the first start codon, so translation starts three codons later and the protein is three amino acids shorter. The T allele ("f") gives the full-length protein (NCBI Gene; Jurutka et al., 2000). In raw data files reported on the genome's forward strand, the same alleles appear as G (F) and A (f).

In laboratory studies, the shorter F protein interacted more efficiently with transcription factor IIB (TFIIB) and had higher transcriptional activity than the full-length f protein (Jurutka et al., 2000). In one cell experiment, activation of a reporter gene was about 1.7-fold greater for the shorter form (Arai et al., 1997). These are measurements in cells, not in people.

A meta-analysis of eight studies (1,038 people) found that the FokI FF genotype was associated with a better response to vitamin D supplementation (p < 0.001) (Usategui-Martin et al., Nutrients, 2022). The authors described the evidence as moderate. Separately, a cross-sectional study of Brazilian adults found higher odds of diabetes in people with the ff genotype (odds ratio 1.78) (Moura et al., Diabetol Metab Syndr, 2024). A cross-sectional association does not show cause.

BsmI (rs1544410), ApaI (rs7975232), and TaqI (rs731236) — The 3' Trio

The other three major VDR polymorphisms — BsmI, ApaI, and TaqI — sit in the 3' region of the VDR gene (intron 8 for BsmI and ApaI, exon 9 for TaqI). They do not change the amino acid sequence of the VDR protein: TaqI is a synonymous change, and BsmI and ApaI are intronic. It has been proposed that they mark differences in VDR mRNA stability, but how, or whether, they change receptor levels is not settled. BsmI and TaqI are in strong linkage disequilibrium, meaning they tend to be inherited together (r² ≈ 0.96 in a European 1000 Genomes sample).

In the same meta-analysis, the TaqI variant allele (Tt or tt genotypes) was associated with a better response to vitamin D supplementation (p = 0.02). BsmI and ApaI showed no significant association in the pooled analysis (p = 0.081 and p = 0.63). For BsmI, individual studies pointed in both directions (Usategui-Martin et al., Nutrients, 2022).

Single nucleotide polymorphism (SNP): a variation at a single position in a DNA sequence, representing the most common type of genetic variation. SNPs in genes like VDR can affect protein structure, mRNA stability, or gene regulation — read more in our guide to SNPs.

What Studies Report About VDR and Supplementation

Supplementation Response in Groups

The meta-analysis by Usategui-Martin and colleagues (2022) pooled eight studies that looked at how VDR genotype relates to the response to vitamin D supplementation. On average, the FokI FF group and carriers of the TaqI variant allele responded better. These are differences between groups in a small number of studies, with moderate evidence.

They do not change what a person should do. There is no CPIC or DPWG guideline, and no clinical guideline we know of, that uses VDR genotype to set a vitamin D dose. Whether someone needs vitamin D, and how much, is decided with a clinician using the serum 25(OH)D blood test.

The Blood Test Comes First

Serum 25(OH)D is the measure clinicians use for vitamin D status. Differences in receptor activity have been measured in cells, but there is no validated way to read a VDR genotype as a correction to a normal 25(OH)D result. A VDR genotype does not replace the blood test or change how it is interpreted.

VDR Gene, Disease Risk, and What the Evidence Actually Shows

Bone Health and Osteoporosis

The connection between VDR and bone health is the most studied and most intuitive — vitamin D's best-known role is calcium absorption and bone mineralization. A meta-analysis of 73 studies by Jiang and colleagues found that the ApaI, BsmI, and TaqI polymorphisms were significantly associated with osteoporosis risk in Caucasians; in Asian populations, the results varied by variant (Archives of Physiology and Biochemistry, published online 2020; 2022;128(6)).

The population specificity is important. A VDR variant that increases osteoporosis risk in one ethnic group may show no association in another. This reflects differences in allele frequencies, linkage disequilibrium patterns, dietary calcium intake, sun exposure, and other environmental modifiers. It is a reminder that genetic risk is always contextual.

Immune Function and Autoimmune Disease

The VDR is expressed in most immune cells — T cells, B cells, macrophages, and dendritic cells. This expression pattern explains why vitamin D deficiency and VDR variants have been linked to immune-related conditions that extend well beyond bone health.

A 2023 review of autoimmune conditions summarised evidence that the TaqI polymorphism plays a role in multiple sclerosis susceptibility, while ApaI associations vary by population. The authors concluded that the ApaI A allele and AA genotype are risk factors shared by multiple sclerosis, Behcet's disease and systemic lupus erythematosus (Agliardi et al., Biology, 2023).

These associations are inconsistent across studies and populations, and the reported effects are small. They describe groups, not an individual's risk, and are not used to assess anyone's risk in clinical practice.

What We Do Not Know Yet

Several important questions remain open. The interaction between VDR genotype and variables like latitude, skin pigmentation, dietary patterns, and gut microbiome composition is not fully mapped. Most studies have been conducted in European or East Asian populations, leaving significant gaps for African, South Asian, and Latin American populations. And the effect sizes for individual VDR variants on disease risk, while statistically significant in meta-analyses, are often modest.

The honest assessment: FokI and TaqI have been associated with supplementation response in groups, and several variants with disease risk in some populations. None of this is used in clinical practice to set a vitamin D dose or replace the blood test.

FAQ — VDR Gene and Vitamin D

Does the VDR gene cause vitamin D deficiency? No. Deficiency is diagnosed with the serum 25(OH)D blood test and is primarily driven by insufficient sun exposure, dietary intake, or absorption issues. VDR variants have been associated with differences in supplementation response in groups, but they do not cause deficiency.

Should I get tested for VDR gene variants? Testing is available through SNP genotyping panels that include rs2228570 (FokI), rs1544410 (BsmI), rs7975232 (ApaI), and rs731236 (TaqI). None of these is clinically actionable: no CPIC, DPWG or other clinical guideline uses VDR genotype to guide vitamin D. If you want to know your vitamin D status, the blood test is what answers that. Our nutrigenomics guide covers the other gene–nutrient interactions they are usually read with.

Should my VDR genotype change how much vitamin D I take? No. There is no validated genotype-based dose. Decisions about vitamin D are made with a clinician, based on the serum 25(OH)D blood test. Very high doses can be harmful, which is another reason not to adjust them on your own.

How common are VDR gene variants? VDR variants are extremely common. In the 1000 Genomes Project, the FokI f allele frequency ranges from about 17% in some African populations to about 38% in Europeans, about 42% in East Asians, and about 69% in one Peruvian sample. BsmI, ApaI, and TaqI variant allele frequencies similarly vary across ethnic groups but are all common polymorphisms, not rare mutations.

A DeepDNA Perspective

VDR is a good example of a gene with a clear biological role and real group-level findings that still do not translate into personal advice. Receptor variants differ in activity in cells, and some are associated with supplementation response in pooled studies. But the decision about vitamin D rests on a blood test and a clinician, not on a genotype.

For related reading, see MTHFR variants (folate metabolism), FTO variants (weight), CYP1A2 variants (caffeine), and lactose tolerance genetics.

Building something that has to answer "what does this variant mean?" DeepDNA is an API for developers and AI agents: gene, variant and drug–gene lookups, each record cited, live and free with no key. Read the API docs.

This article was created with AI assistance and reviewed by the DeepDNA editorial team.